Glioblastoma Cancer Stem Cells Evade Innate Immune Suppression of Self-Renewal through Reduced TLR4 Expression.

[1]  Asha A. Nair,et al.  Retinoblastoma Binding Protein 4 Modulates Temozolomide Sensitivity in Glioblastoma by Regulating DNA Repair Proteins. , 2016, Cell reports.

[2]  B. Naini,et al.  TLR4 Signaling via NANOG Cooperates With STAT3 to Activate Twist1 and Promote Formation of Tumor-Initiating Stem-Like Cells in Livers of Mice. , 2016, Gastroenterology.

[3]  S. Markowitz,et al.  Human Colon Tumors Express a Dominant-Negative Form of SIGIRR That Promotes Inflammation and Colitis-Associated Colon Cancer in Mice. , 2015, Gastroenterology.

[4]  Nupur K. Das,et al.  Preferential Iron Trafficking Characterizes Glioblastoma Stem-like Cells. , 2015, Cancer cell.

[5]  G. Stark,et al.  Erlotinib protects against LPS-induced Endotoxicity because TLR4 needs EGFR to signal , 2015, Proceedings of the National Academy of Sciences.

[6]  J. Rich,et al.  Cancer stem cells in glioblastoma , 2015, Genes & development.

[7]  D. Sahoo,et al.  CD14-expressing cancer cells establish the inflammatory and proliferative tumor microenvironment in bladder cancer , 2015, Proceedings of the National Academy of Sciences.

[8]  F. Heppner,et al.  Glioma-derived versican promotes tumor expansion via glioma-associated microglial/macrophages Toll-like receptor 2 signaling. , 2015, Neuro-oncology.

[9]  Yuan Qiao,et al.  Recent advances in the role of toll-like receptors and TLR agonists in immunotherapy for human glioma , 2014, Protein & Cell.

[10]  G. Gallia,et al.  TLR9 is critical for glioma stem cell maintenance and targeting. , 2014, Cancer research.

[11]  R. Schwabe,et al.  The Yin and Yang of Toll-like receptors in cancer , 2014, Oncogene.

[12]  Simon Kasif,et al.  Reconstructing and Reprogramming the Tumor-Propagating Potential of Glioblastoma Stem-like Cells , 2014, Cell.

[13]  H. Kettenmann,et al.  Toll-like receptor 2 mediates microglia/brain macrophage MT1-MMP expression and glioma expansion. , 2013, Neuro-oncology.

[14]  E. Elinav,et al.  Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms , 2013, Nature Reviews Cancer.

[15]  D. Haussler,et al.  The Somatic Genomic Landscape of Glioblastoma , 2013, Cell.

[16]  S. Dooley,et al.  Reciprocal regulation by TLR4 and TGF-β in tumor-initiating stem-like cells. , 2013, The Journal of clinical investigation.

[17]  Douglas Golenbock,et al.  The history of Toll-like receptors — redefining innate immunity , 2013, Nature Reviews Immunology.

[18]  J. Barnholtz-Sloan,et al.  CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. , 2012, Neuro-oncology.

[19]  Tzong-Shiue Yu,et al.  A restricted cell population propagates glioblastoma growth following chemotherapy , 2012, Nature.

[20]  J. Visvader,et al.  Cancer stem cells: current status and evolving complexities. , 2012, Cell stem cell.

[21]  C. Vakoc,et al.  WRAD: enabler of the SET1-family of H3K4 methyltransferases. , 2012, Briefings in functional genomics.

[22]  Raul Rabadan,et al.  Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. , 2012, Cancer cell.

[23]  S. Lepreux,et al.  TLR4 signal transduction pathways neutralize the effect of Fas signals on glioblastoma cell proliferation and migration. , 2011, Cancer letters.

[24]  E. Sen,et al.  Involvement of TNFα-induced TLR4–NF-κB and TLR4–HIF-1α feed-forward loops in the regulation of inflammatory responses in glioma , 2011, Journal of Molecular Medicine.

[25]  Daniel J. Hoeppner,et al.  Distribution of CD133 reveals glioma stem cells self-renew through symmetric and asymmetric cell divisions , 2011, Cell Death and Disease.

[26]  A. Sloan,et al.  Hypoxia-induced mixed-lineage leukemia 1 regulates glioma stem cell tumorigenic potential , 2011, Cell Death and Differentiation.

[27]  R. McLendon,et al.  Acidic stress promotes a glioma stem cell phenotype , 2011, Cell Death and Differentiation.

[28]  J. Baselga,et al.  TGF-β Receptor Inhibitors Target the CD44(high)/Id1(high) Glioma-Initiating Cell Population in Human Glioblastoma. , 2010, Cancer cell.

[29]  A. Rosenwald,et al.  Toll-like receptor (TLR) 7 and TLR8 expression on CD133+ cells in colorectal cancer points to a specific role for inflammation-induced TLRs in tumourigenesis and tumour progression. , 2010, European journal of cancer.

[30]  R. Galli,et al.  Epidermal growth factor receptor expression identifies functionally and molecularly distinct tumor-initiating cells in human glioblastoma multiforme and is required for gliomagenesis. , 2010, Cancer research.

[31]  Emmette R. Hutchison,et al.  TLR2 activation inhibits embryonic neural progenitor cell proliferation , 2010, Journal of neurochemistry.

[32]  G. Smyth,et al.  ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. , 2009, Journal of immunological methods.

[33]  Bangxing Hong,et al.  Embryonic Stem Cells and Mammary Luminal Progenitors Directly Sense and Respond to Microbial Products , 2009, Stem cells.

[34]  Hui Wang,et al.  Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. , 2009, Cancer cell.

[35]  Tatsuya Ozawa,et al.  PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. , 2009, Cell stem cell.

[36]  Sung-Chun Tang,et al.  Toll-like receptors in neurodegeneration , 2009, Brain Research Reviews.

[37]  A. Ribas,et al.  HMGB1 Mediates Endogenous TLR2 Activation and Brain Tumor Regression , 2009, PLoS medicine.

[38]  M. Mattson,et al.  Toll-Like Receptor 3 Is a Negative Regulator of Embryonic Neural Progenitor Cell Proliferation , 2008, The Journal of Neuroscience.

[39]  R. McLendon,et al.  Brain Cancer Stem Cells Display Preferential Sensitivity to Akt Inhibition , 2008, Stem cells.

[40]  M. Schwartz,et al.  Toll-like receptor 4 restricts retinal progenitor cell proliferation , 2008, The Journal of cell biology.

[41]  Yaniv Ziv,et al.  Toll-like receptors modulate adult hippocampal neurogenesis , 2007, Nature Cell Biology.

[42]  M. Bianchi.  DAMPs, PAMPs and alarmins: all we need to know about danger , 2007, Journal of leukocyte biology.

[43]  Mark W. Dewhirst,et al.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response , 2006, Nature.

[44]  J. Antel,et al.  TLR Signaling Tailors Innate Immune Responses in Human Microglia and Astrocytes1 , 2005, The Journal of Immunology.

[45]  P. Angel,et al.  AP-1 subunits: quarrel and harmony among siblings , 2004, Journal of Cell Science.

[46]  R. Henkelman,et al.  Identification of human brain tumour initiating cells , 2004, Nature.

[47]  M. Chicoine,et al.  Intratumoral Injection of Lipopolysaccharide Causes Regression of Subcutaneously Implanted Mouse Glioblastoma Multiforme , 2001, Neurosurgery.

[48]  Robert L Bowman,et al.  GlioVis data portal for visualization and analysis of brain tumor expression datasets. , 2017, Neuro-oncology.

[49]  J. Ho,et al.  A tumorigenic MLL-homeobox network in human glioblastoma stem cells. , 2013, Cancer research.

[50]  J. V. van Noort,et al.  Toll-like receptors in the CNS: implications for neurodegeneration and repair. , 2009, Progress in brain research.